Skip to content
2000
Volume 23, Issue 1
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

Introduction

Metastatic melanoma poses a significant threat globally, with a distressingly low ten-year survival rate of only 10%. While FDA-approved treatments such as dacarbazine and high-dose IL-2 have been employed in clinical settings, their limitations underscore the urgent need for more effective therapies.

Aim

This study aimed to develop a potential anticancer local treatment through the extraction of various amounts of ginger extract loaded into Poly(vinyl alcohol) (PVA) nanofibers.

Methods

The anticancer activity of the produced membranes was studied on human skin melanoma B16F10 cells. Other experiments such as cell migration assay, cell proliferation assay, cell viability assay, scanning electron microscopy assay, real-time PCR assay, and ant-inflammatory assay were performed for the characterization of the delivery system. Tissue toxicity of the developed patches was studied in a rat model.

Results

The study showed that scaffolds loaded with 2%, 4%, 6%, 8%, and 0% of ginger extract had around 784.98 ± 202.31 nm, 771.86 ± 219.07 nm, 820.65 ± 242.43 nm, 785.19 ± 203.99 nm, and 671.29 ± 184.09 nm of mean fiber size, respectively. The ginger extract-loaded membranes suppressed the growth and migration activity of human skin melanoma B16F10 cells in a dose and time-dependent manner. Real-time PCR assay showed that the developed membranes modulated the expression levels of Ras/ERK and PI3K/AKT signaling pathways. Animal study results showed that our developed patches were not toxic against liver or skin tissues.

Conclusion

Ginger extract-loaded PVA nanofibers exhibited promising anticancer potential against melanoma cells, suggesting a viable localized treatment option.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdd/10.2174/0115672018319584241008075033
2024-10-15
2026-02-16

  • From This Site

    /content/journals/cdd/10.2174/0115672018319584241008075033
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. VandyckH.H.L.D. HillenL.M. BosisioF.M. van den OordJ. zur HausenA. WinnepenninckxV. Rethinking the biology of metastatic melanoma: A holistic approach.Cancer Metastasis Rev.202140260362410.1007/s10555‑021‑09960‑833870460
     [Google Scholar]
  2. BjørchM.F. GramE.G. BrodersenJ.B. Overdiagnosis in malignant melanoma: A scoping review.BMJ Evid. Based Med.2024291172810.1136/bmjebm‑2023‑11234137793786
     [Google Scholar]
  3. TønderJ.E. Bønnelykke-BehrndtzM.L. LaurbergT. RøssellE.L. SollieM. Melanoma risk, tumour stage, and melanoma-specific mortality in individuals with diabetes: a systematic review and meta-analysis.BMC Cancer202424181210.1186/s12885‑024‑12598‑838972968
     [Google Scholar]
  4. de BreeE. Complications of Surgery for Cutaneous Melanoma.Side Effects of Cancer TherapySpringer: Cham202410.1007/978‑3‑030‑93702‑7_36‑1
     [Google Scholar]
  5. CarabanB.M. AschieM. DeacuM. CozaruG.C. PundicheM.B. OrasanuC.I. VodaR.I. A Narrative Review of Current Knowledge on Cutaneous Melanoma.Clin. Pract.202414121424110.3390/clinpract1401001838391404
     [Google Scholar]
  6. KurykL. BertinatoL. StaniszewskaM. PancerK. WieczorekM. SalmasoS. CalicetiP. GarofaloM. From conventional therapies to immunotherapy: melanoma treatment in review.Cancers (Basel)20201210305710.3390/cancers1210305733092131
     [Google Scholar]
  7. PatelH. YacoubN. MishraR. WhiteA. YuanL. AlanaziS. GarrettJ.T. Current advances in the treatment of BRAF-mutant melanoma.Cancers (Basel)202012248210.3390/cancers1202048232092958
     [Google Scholar]
  8. SwitzerB. PuzanovI. SkitzkiJ.J. HamadL. ErnstoffM.S. Managing metastatic melanoma in 2022: a clinical review.JCO Oncol. Pract.202218533535110.1200/OP.21.0068635133862
     [Google Scholar]
  9. RobertsonB.M. Determinants of resistance and response to melanoma therapy.Nat Cancer.202457964982
     [Google Scholar]
  10. NatarelliN. AlemanS.J. MarkI.M. TranJ.T. KwakS. BottoE. AflatooniS. DiazM.J. LipnerS.R. A review of current and pipeline drugs for treatment of melanoma.Pharmaceuticals (Basel)202417221410.3390/ph1702021438399429
     [Google Scholar]
  11. RoutyB. JacksonT. MählmannL. BaumgartnerC.K. BlaserM. ByrdA. CorvaiaN. CoutsK. DavarD. DerosaL. HangH.C. HospersG. IsaksenM. KroemerG. MalardF. McCoyK.D. MeiselM. PalS. RonaiZ. SegalE. Sepich-PooreG.D. ShaikhF. SweisR.F. TrinchieriG. van den BrinkM. WeersmaR.K. WhitesonK. ZhaoL. McQuadeJ. ZarourH. ZitvogelL. Melanoma and microbiota: Current understanding and future directions.Cancer Cell2024421163410.1016/j.ccell.2023.12.00338157864
     [Google Scholar]
  12. ViegasJ. SarmentoB. Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research.Adv. Drug Deliv. Rev.202420811529510.1016/j.addr.2024.11529538527625
     [Google Scholar]
  13. KowalskiS. KarskaJ. TotaM. SkinderowiczK. KulbackaJ. Drąg-ZalesińskaM. Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment.Molecules202429372810.3390/molecules2903072838338469
     [Google Scholar]
  14. ImtiazI. SchlossJ. BugarcicA. Traditional and contemporary herbal medicines in management of cancer: A scoping review.J. Ayurveda Integr. Med.202415110090410.1016/j.jaim.2024.10090438395014
     [Google Scholar]
  15. BakrA.F. Ginger extract and ginger nanoparticles; Characterization and applications.J. Vet. Sci.202092203209
     [Google Scholar]
  16. KamaruddinM.S.H. ChongG.H. Mohd DaudN. PutraN.R. Md SallehL. SuleimanN. Bioactivities and green advanced extraction technologies of ginger oleoresin extracts: A review.Food Res. Int.202316411228310.1016/j.foodres.2022.11228336737895
     [Google Scholar]
  17. Garza-CadenaC. Ortega-RiveraD.M. Machorro-GarcíaG. Gonzalez-ZermeñoE.M. Homma-DueñasD. Plata-GrylM. Castro-MuñozR. A comprehensive review on Ginger (Zingiber officinale) as a potential source of nutraceuticals for food formulations: Towards the polishing of gingerol and other present biomolecules.Food Chem.202341313562910.1016/j.foodchem.2023.13562936753787
     [Google Scholar]
  18. KiyamaR. Nutritional implications of ginger: chemistry, biological activities and signaling pathways.J. Nutr. Biochem.20208610848610.1016/j.jnutbio.2020.10848632827666
     [Google Scholar]
  19. NutakorC. EssieduJ.A. AdadiP. KanwuguO.N. Ginger beer: An overview of health benefits and recent developments.Fermentation (Basel)20206410210.3390/fermentation6040102
     [Google Scholar]
  20. OsmanA.M.E. In vitro anticancer and cytotoxic activity of ginger extract on human breast cell lines.Khartoum Journal of Pharmaceutical Sciences2020112629
     [Google Scholar]
  21. CojocaruS.I. StanM. StoianG. DinischiotuA. Effects of zingiber officinale roscoe fresh extract on amelanotic melanoma and normal skin fibroblasts.Rev. Med. Chir. Soc. Med. Nat. Iasi2015119259259626204672
     [Google Scholar]
  22. AdikesavanM. AthirajaP. DivakarM.B.B. Investigation on the anticancer activity of [6]-gingerol of Zingiber officinale and its structural analogs against skin cancer.Curr. Computeraided Drug Des.202420436737310.2174/157340991966623041809510537076965
     [Google Scholar]
  23. LuraghiA. PeriF. MoroniL. Electrospinning for drug delivery applications: A review.J. Control. Release202133446348410.1016/j.jconrel.2021.03.03333781809
     [Google Scholar]
  24. ZahraF.T. QuickQ. MuR. Electrospun PVA fibers for drug delivery: A review.Polymers (Basel)20231518383710.3390/polym1518383737765691
     [Google Scholar]
  25. Rivera-HernándezG. Antunes-RicardoM. Martínez-MoralesP. SánchezM.L. Polyvinyl alcohol based-drug delivery systems for cancer treatment.Int. J. Pharm.202160012047810.1016/j.ijpharm.2021.12047833722756
     [Google Scholar]
  26. AbdelbassetW.K. ElkholiS.M. IsmailK.A. AL-GhamdiH.S. MironovS. RidhaH.S.H. MaashiM.S. ThangaveluL. MahmudionoT. MustafaY.F. Mequinol-loaded carboxymethyl cellulose/chitosan electrospun wound dressing as a potential candidate to treat diabetic wounds.Cellulose202229147863788110.1007/s10570‑022‑04753‑w
     [Google Scholar]
  27. ŽitekT. BjelićD. KotnikP. GolleA. JurgecS. PotočnikU. KnezŽ. FinšgarM. KrajncI. KrajncI. MarevciM.K. Natural hemp-ginger extract and its biological and therapeutic efficacy.Molecules20222722769410.3390/molecules2722769436431795
     [Google Scholar]
  28. WengC.J. WuC.F. HuangH.W. HoC.T. YenG.C. Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells.Mol. Nutr. Food Res.201054111618162710.1002/mnfr.20100010820521273
     [Google Scholar]
  29. WangL.X. QianJ. ZhaoL.N. ZhaoS.H. Effects of volatile oil from ginger on the murine B16 melanoma cells and its mechanism.Food Funct.2018921058106910.1039/C7FO01127J29355275
     [Google Scholar]
  30. LechnerJ.F. StonerG.D. Gingers and their purified components as cancer chemopreventative agents.Molecules20192416285910.3390/molecules2416285931394732
     [Google Scholar]
  31. KaewtunjaiN. WongpoomchaiR. ImsumranA. PompimonW. AthipornchaiA. SuksamrarnA. LeeT.R. TuntiwechapikulW. Ginger extract promotes telomere shortening and cellular senescence in A549 lung cancer cells.ACS Omega2018312185721858110.1021/acsomega.8b0285332010796
     [Google Scholar]
  32. HuangH.C. ChiuS.H. ChangT.M. Inhibitory effect of [6]-gingerol on melanogenesis in B16F10 melanoma cells and a possible mechanism of action.Biosci. Biotechnol. Biochem.20117561067107210.1271/bbb.10085121670536
     [Google Scholar]
  33. YusofY.A. AhmadN. DasS. SulaimanS. MuradN.A. Chemopreventive efficacy of ginger (Zingiber officinale) in ethionine induced rat hepatocarcinogenesis.Afr. J. Tradit. Complement. Altern. Med.200861879320162046
     [Google Scholar]
  34. StoilovaI. KrastanovA. StoyanovaA. DenevP. GargovaS. Antioxidant activity of a ginger extract (Zingiber officinale).Food Chem.2007102376477010.1016/j.foodchem.2006.06.023
     [Google Scholar]
  35. SiW. ChenY.P. ZhangJ. ChenZ.Y. ChungH.Y. Antioxidant activities of ginger extract and its constituents toward lipids.Food Chem.20182391117112510.1016/j.foodchem.2017.07.05528873530
     [Google Scholar]
  36. AnS. LiuG. GuoX. AnY. WangR. Ginger extract enhances antioxidant ability and immunity of layers.Anim. Nutr.20195440740910.1016/j.aninu.2019.05.00331890918
     [Google Scholar]
  37. MasudaY. KikuzakiH. HisamotoM. NakataniN. Antioxidant properties of gingerol related compounds from ginger.Biofactors2004211-429329610.1002/biof.55221015715630214
     [Google Scholar]
  38. NeaguM. ConstantinC. CaruntuC. DumitruC. SurcelM. ZuracS. Inflammation: A key process in skin tumorigenesis.Oncol. Lett.20191754068408430944600
     [Google Scholar]
  39. ZhouX. AfzalS. WohlmuthH. MünchG. LeachD. LowM. LiC.G. Synergistic anti-inflammatory activity of ginger and turmeric extracts in inhibiting lipopolysaccharide and interferon-γ-induced proinflammatory mediators.Molecules20222712387710.3390/molecules2712387735745000
     [Google Scholar]
  40. PappalardoF. RussoG. CandidoS. PennisiM. CavalieriS. MottaS. McCubreyJ.A. NicolettiF. LibraM. Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer.PLoS One2016113e015210410.1371/journal.pone.015210427015094
     [Google Scholar]
  41. CaloriI.R. BragaG. de JesusP.C.C. BiH. TedescoA.C. Polymer scaffolds as drug delivery systems.Eur. Polym. J.202012910962110.1016/j.eurpolymj.2020.109621
     [Google Scholar]
  42. EbadiM. BulloS. BuskaraK. HusseinM.Z. FakuraziS. PastorinG. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.Sci. Rep.20201012152110.1038/s41598‑020‑76504‑533298980
     [Google Scholar]
  43. RondanelliM. FossariF. VecchioV. GasparriC. PeroniG. SpadacciniD. RivaA. PetrangoliniG. IannelloG. NichettiM. InfantinoV. PernaS. Clinical trials on pain lowering effect of ginger: A narrative review.Phytother. Res.202034112843285610.1002/ptr.673032436242
     [Google Scholar]
/content/journals/cdd/10.2174/0115672018319584241008075033
Loading
Local Delivery of Ginger Extract via a Nanofibrous Membrane Suppresses Human Skin Melanoma B16F10 Cells Growth via Targeting Ras/ERK and PI3K/AKT Signaling Pathways: An In vitro Study
Curr. Drug Deliv. 23, 101 (2026); https://doi.org/10.2174/0115672018319584241008075033
/content/journals/cdd/10.2174/0115672018319584241008075033
/content/journals/cdd/10.2174/0115672018319584241008075033
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): drug delivery, anti-cancer, local treatment, melanoma; Ginger; nanofibers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test